Department of Medicine

IU Infectious Diseases Laboratory


More data support efficacy of GEN-003 therapeutic vaccine for HSV-2 (Jul, 2016)

Three doses of a novel therapeutic DNA vaccine for genital herpes reduced viral shedding and genital lesion formation.


Indiana CTSI cores and IU Kelley MBA students pair to improve processes, workflows (Jun, 2016)

In a project with the IU Infectious Disease Laboratory (IDL), MBA students outlined a plan to increase the awareness of the Infections Disease Laboratory on the IU School of Medicine campus.


First Therapeutic Vaccine for Genital Herpes Reduces Signs of Infection for One Year (Jun 22, 2016)

A therapeutic vaccine for genital herpes has the potential to reduce viral activity as well as decrease the number of days of recurrent herpes.


A New Way To Screen For Cervical Cancer  (Jun 9, 2014)

(link is no longer active)


Could a new HPV test change cervical cancer screenings?  (May 27, 2014)

FDA approves the use of a new human papillomavirus test for primary cervical cancer screening.


Gonorrhea Resistant to Antibiotics on the Rise  (Feb 9, 2012)

The New England Journal of Medicine highlights the concern for the rising rate of antibiotic-resistant gonorrhea in the U.S.


Control of herpes symptoms does not reduce HIV transmission, international study found  (Jan 25, 2010)

Five preliminary studies showed that it is possible to decrease the amount of HIV in the blood and genital tract through treatment to suppress HSV-2.